Galanin Inhibits Histaminergic Neurons via Galanin Receptor 1 Galanin-expressing neurons in the ventrolateral preoptic area (VLPOgalanin) are active during sleep and play an important role in regulating non-rapid eye movement (NREM) sleep. It is generally believ...

🚨 new paper from the lab 🚨 exploring how the #sleep promoting neuropeptide #galanin regulates the activity of #wake active histaminergic neurons in the #hypothalamus.

www.eneuro.org/content/13/2...

INNOVATIVE SCIENCE TO TRANSFORMATIONAL CARE The preeminent international conference for obesity researchers and clinicians, ObesityWeek® is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical resea...

If your attending #ObesityWeek 2025 and interested in the role of the brain 🧠 in body weight & metabolic regulation, come join us at the #Neuroscience Section Meeting, Wednesday 5th from 5:30 in A315-316, for some blitz talks & networking opportunities with likeminded colleagues.
obesityweek.org

Comment un médicament contre l'épilepsie fait perdre du poids Une équipe de recherche établit comment la molécule coupe-faim contenue dans le Qsymia agit sur le cerveau

Comment un médicament contre l'épilepsie fait perdre du poids: l'effet du topiramate, contenu dans le Qsymia, sur le cerveau

SRSF Career Development Award - Sleep Research Society The goal of these awards is to invest in promising early career researchers and assist with their transition into independence as junior investigators.

✨SRSF Career Development Award applications are now open! ✨These awards serve as a great steppingstone towards independence for postdoctoral #sleep researchers 🔬🧬

Abstract Submissions - ObesityWeek® ObesityWeek regular call for abstracts is open in March and April each year. The Late-Breaking Call for Abstracts is open in June and July each year.

#ObesityWeek abstract submissions are now open - until April 7th!

The #ObesitySociety Neuroscience Section has been hard at work over the past 2 years!

I am excited to share our previous webinars focused on obesity research, funding strategies, and science communication. Join us to learn from leading experts in academia, industry, and more!

👇Thread👇

Me too please 😇

FDA Approves First Medication for Obstructive Sleep Apnea Today, the FDA approved the first medication for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

GLP1R agonists approved for obstructive sleep apnea.
www.fda.gov/news-events/...

Mapping neuropeptide signaling in the human brain | doi.org/10.1101/2024...

Neuropeptides are among the functionally diverse signaling molecules in the brain and body.

@cebric.bsky.social curates an atlas of neuropeptide receptors and relates it brain function 🧩 🧠 ⤵️

Yes please!

Wow… super cool colours 😍Congrats!

Congratulations to Axelle, PhD student from the lab, for her award at the Faculty Research Day!